462 related articles for article (PubMed ID: 19642499)
1. [Fetal and neonatal outcomes in infants of mothers with TSH receptor antibody positivity in pregnancy].
Zuppa AA; Perrone S; Sindico P; Alighieri G; Antichi E; Carducci C; Romagnoli C
Pediatr Med Chir; 2009; 31(2):72-7. PubMed ID: 19642499
[TBL] [Abstract][Full Text] [Related]
2. Neonatal hyperthyroidism: neonatal clinical course of two brothers born to a mother with Graves-Basedow disease, before and after total thyroidectomy.
Zuppa AA; Sindico P; Savarese I; D'Andrea V; Fracchiolla A; Cota F; Romagnoli C
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):535-9. PubMed ID: 17550218
[TBL] [Abstract][Full Text] [Related]
3. Management of neonates born to women with Graves' disease: a cohort study.
Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
5. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
6. [Neonatal hyperthyroidism in a premature infant born to a mother with Grave's disease].
Nicaise C; Gire C; Brémond V; Minodier P; Soula F; d'Ercole C; Palix C
Arch Pediatr; 2000 May; 7(5):505-8. PubMed ID: 10855389
[TBL] [Abstract][Full Text] [Related]
7. Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism.
Pyrżak B; Rumińska M; Witkowska-Sędek E; Kucharska A
Front Endocrinol (Lausanne); 2022; 13():877119. PubMed ID: 35600602
[TBL] [Abstract][Full Text] [Related]
8. [Neonatal hyperthyroidism caused by TSH receptor antibodies in maternal autoimmune hyperthyroidism].
Resch B; Mache C; Rosegger H; Häusler M
Z Geburtshilfe Neonatol; 1995; 199(6):248-52. PubMed ID: 8581851
[TBL] [Abstract][Full Text] [Related]
9. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].
Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J
Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569
[TBL] [Abstract][Full Text] [Related]
10. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
Suzuki N; Yoshihara A; Yoshimura Noh J; Kinoshita K; Ohnishi J; Saito M; Sugino K; Ito K
Endocr J; 2020 Oct; 67(10):1019-1022. PubMed ID: 32522908
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay.
Massart C; Gibassier J; d'Herbomez M
Clin Chim Acta; 2009 Sep; 407(1-2):62-6. PubMed ID: 19576193
[TBL] [Abstract][Full Text] [Related]
12. [Characterization of children born to mothers with Graves' disease].
Muñoz Pérez T; Peña Manubens MF; Román Reyes R; Riquelme Romero J
Andes Pediatr; 2021 Aug; 92(4):556-564. PubMed ID: 34652374
[TBL] [Abstract][Full Text] [Related]
13. Severe fetal and neonatal hyperthyroidism years after surgical treatment of maternal Graves' disease.
Dierickx I; Decallonne B; Billen J; Vanhole C; Lewi L; De Catte L; Verhaeghe J
J Obstet Gynaecol; 2014 Feb; 34(2):117-22. PubMed ID: 24456429
[TBL] [Abstract][Full Text] [Related]
14. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
[TBL] [Abstract][Full Text] [Related]
15. [Development of neonatal Graves' disease--prediction, prevention and treatment].
Matsuura N
Nihon Rinsho; 2006 Dec; 64(12):2303-7. PubMed ID: 17154096
[TBL] [Abstract][Full Text] [Related]
16. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease.
McNab T; Ginsberg J
Clin Invest Med; 2005 Jun; 28(3):127-31. PubMed ID: 16021986
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
Bojarska-Szmygin A; Ciechanek R
Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
[TBL] [Abstract][Full Text] [Related]
18. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
Skuza KA; Sills IN; Stene M; Rapaport R
J Pediatr; 1996 Feb; 128(2):264-8. PubMed ID: 8636826
[TBL] [Abstract][Full Text] [Related]
19. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism.
Abeillon-du Payrat J; Chikh K; Bossard N; Bretones P; Gaucherand P; Claris O; Charrié A; Raverot V; Orgiazzi J; Borson-Chazot F; Bournaud C
Eur J Endocrinol; 2014 Oct; 171(4):451-60. PubMed ID: 25214232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
